Home › Prostate Cancer › Wisconsin
Prostate Cancer clinical trials in Wisconsin
47 studies for Prostate Cancer are looking for participants at sites in Wisconsin.
Cities in Wisconsin
- Madison29 studies
- Milwaukee20 studies
- Wausau7 studies
- Stevens Point7 studies
- Green Bay6 studies
- Eau Claire5 studies
- West Bend5 studies
- Watertown4 studies
- Sheboygan4 studies
- Oshkosh4 studies
- Racine4 studies
- Manitowoc3 studies
- Kenosha3 studies
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
- University of Wisconsin Carbone Cancer Center, Madison
RecruitingPhase 1/2
Ages 12 and older · All sexes · Updated Oct 2, 2026 · NCT04585750Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial
- Aspirus Cancer Care-Antigo-Volm Cancer Center, Antigo
- ThedaCare Regional Cancer Center, Appleton
- Ascension Northeast Wisconsin-Saint Elizabeth Cancer Center-Appleton, Appleton
- and 25 more
RecruitingPhase 3
Ages 18 and older · Men · Updated Oct 2, 2026 · NCT06931340Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial
- Froedtert Menomonee Falls Hospital, Menomonee Falls
- Medical College of Wisconsin, Milwaukee
- Froedtert and MCW Moorland Reserve Health Center, New Berlin
- and 2 more
RecruitingPhase 3
Ages 18 and older · Men · Updated Oct 2, 2026 · NCT07200830Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- Aspirus Cancer Care-Antigo-Volm Cancer Center, Antigo
- ThedaCare Regional Cancer Center, Appleton
- ThedaCare Regional Medical Center - Appleton, Appleton
- and 50 more
RecruitingObservational studyHealthy volunteers welcome
Ages 40 to 75 · All sexes · Updated Oct 2, 2026 · NCT05334069Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial
- Marshfield Medical Center-Marshfield, Marshfield
- Froedtert Menomonee Falls Hospital, Menomonee Falls
- Medical College of Wisconsin, Milwaukee
- and 2 more
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Oct 2, 2026 · NCT06632977PET/CT Characterization of Treatment Resistance
- University of Wisconsin, Madison
Recruiting
Ages 18 and older · Men · Updated Oct 1, 2026 · NCT05647564Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
- Duluth Clinic Ashland, Ashland
- Aurora Cancer Care-Southern Lakes VLCC, Burlington
- Marshfield Medical Center-EC Cancer Center, Eau Claire
- and 25 more
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 30, 2026 · NCT03866382A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
- Medical College of Wisconsin ( Site 0020), Milwaukee
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT06136650This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
- University of Wisconsin Carbone Cancer Center - Eastpark Medical Center, Madison
- University of Wisconsin Carbone Cancer Center - University Hospital, Madison
RecruitingPhase 3
Ages 18 and older · Men · Updated Sep 24, 2026 · NCT07028853Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy
- Medical College Of Wisconsin, Milwaukee
RecruitingPhase 2/3
Ages 18 to 100 · Men · Updated Sep 22, 2026 · NCT06780670Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC
- Medical College of Wisconsin, Milwaukee
RecruitingPhase 3
Ages 18 to 100 · Men · Updated Sep 22, 2026 · NCT06855277High Dose Testosterone for ATM, CDK12 or CHEK2 Altered Prostate Cancers
- William S. Middleton Memorial Veterans Hospital, Madison, WI, Madison
RecruitingPhase 2
Ages 18 and older · Men · Updated Sep 17, 2026 · NCT05011383Carboplatin or Olaparib for BRcA Deficient Prostate Cancer
- William S. Middleton Memorial Veterans Hospital, Madison, WI, Madison
RecruitingPhase 2
Ages 18 and older · Men · Updated Sep 17, 2026 · NCT04038502A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
- University Hospital and UW Health Clinics ( Site 0065), Madison
- Medical College of Wisconsin ( Site 0008), Milwaukee
RecruitingPhase 3
Ages 18 and older · Men · Updated Sep 17, 2026 · NCT06925737MDRT in Prostate Cancer Treated With Long-term Androgen Deprivation Therapy in the STAMPEDE Trial (METANOVA)
- Carbone Cancer Center University of Wisconsin-Madison, Madison
RecruitingPhase 2
Ages 18 and older · Men · Updated Sep 15, 2026 · NCT06150417Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy
- University of Wisconsin, Madison
RecruitingPhase 3
Ages 18 and older · Men · Updated Sep 11, 2026 · NCT06056830Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
- Langlade Hospital and Cancer Center, Antigo
- Duluth Clinic Ashland, Ashland
- Northwest Wisconsin Cancer Center, Ashland
- and 36 more
RecruitingPhase 3
Ages 18 and older · Men · Updated Sep 10, 2026 · NCT05946213Pacritinib in Participants With Metastatic Castrate-Resistant Prostate Cancer That Progressed on or After Prior Treatment With Androgen Receptor Signaling Inhibitors
- Froedtert & the Medical College of Wisconsin, Milwaukee
RecruitingPhase 2
Ages 18 and older · Men · Updated Sep 9, 2026 · NCT07226713A Phase 2 Study to Evaluate the Effects of ASP5541 in Participants With Prostate Cancer
- UW Health Carbone Cancer Center, Madison
RecruitingPhase 2
Ages 18 and older · Men · Updated Sep 3, 2026 · NCT07005154The Vanguard Study: Testing a New Way to Screen for Cancer
- Zablocki Veterans Administration Medical Center, Milwaukee
RecruitingHealthy volunteers welcome
Ages 45 to 75 · All sexes · Updated Sep 2, 2026 · NCT06995898Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma
- Froedtert Hospital & the Medical College of Wisconsin, Milwaukee
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Aug 27, 2026 · NCT06582017COMPASS Study for Metastatic Castration-resistant Prostate Cancer
- University of Wisconsin Carbone Cancer Center, Madison
RecruitingObservational study
Ages 18 and older · Men · Updated Aug 27, 2026 · NCT07050433A Study of Talazoparib With or Without Enzalutamide in People With Prostate Cancer Who Have Previously Received Abiraterone Acetate or Darolutamide
- University of Wisconsin Carbone Cancer Center-Madison, Madison
RecruitingPhase 2
Ages 18 and older · Men · Updated Aug 21, 2026 · NCT06844383Dosing Physical Activity Among Older Cancer Survivors Who Experience Chronic Pain: a Micro-randomized Trial
- Froedtert Hospital, Milwaukee
Recruiting
Ages 65 and older · All sexes · Updated Aug 20, 2026 · NCT07227077Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
- Aspirus Cancer Care-Antigo-Volm Cancer Center, Antigo
- Marshfield Medical Center-EC Cancer Center, Eau Claire
- University of Wisconsin Carbone Cancer Center - Johnson Creek, Johnson Creek
- and 13 more
RecruitingPhase 3
Ages 18 and older · Men · Updated Aug 19, 2026 · NCT04423211FOG-001 in Locally Advanced or Metastatic Solid Tumors
- University of Wisconsin, Carbone Cancer Center, Madison
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Aug 17, 2026 · NCT05919264Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)
- University of Wisconsin Carbone Cancer Center, Madison
- Froedtert Hospital and the Medical College of Wisconsin, Milwaukee
RecruitingPhase 1
Ages 18 to 100 · Men · Updated Aug 13, 2026 · NCT05519449Impact of DNA Repair Pathway Alterations on Sensitivity to Radium-223 in Bone Metastatic Castration-resistant Prostate Cancer
- University of Wisconsin-Madison, Madison
RecruitingObservational study
Ages 18 and older · Men · Updated Aug 12, 2026 · NCT04489719Evaluation of Neoadjuvant Xaluritamig in Localized Prostate Cancer
- Medical College of Wisconsin, Milwaukee
RecruitingPhase 1
Ages 18 and older · Men · Updated Jul 31, 2026 · NCT06613100Adaptive Radiation Therapy (ART) Stereotactic Ablative Body Radiotherapy (SABR) for Primary Localized Prostate Cancer
- Mayo Clinic Health System-Eau Claire, Eau Claire
- Mayo Clinic Health System-Franciscan Healthcare, La Crosse
Recruiting
Ages 18 and older · Men · Updated Jul 30, 2026 · NCT06325046Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
- Duluth Clinic Ashland, Ashland
- Northwest Wisconsin Cancer Center, Ashland
- Marshfield Medical Center-EC Cancer Center, Eau Claire
- and 10 more
RecruitingPhase 3
Ages 18 and older · Men · Updated Jul 14, 2026 · NCT06592924Testing the Safety and Effectiveness of Radiation-based Treatment (Lutetium Lu 177 Dotatate) for Metastatic Prostate Cancer That Has Neuroendocrine Cells
- University of Wisconsin Carbone Cancer Center - Eastpark Medical Center, Madison
- University of Wisconsin Carbone Cancer Center - University Hospital, Madison
RecruitingPhase 2
Ages 18 and older · Men · Updated Jul 14, 2026 · NCT05691465A Clinical Study of KTX-2001 in Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)
- University of Wisconsin, Madison
RecruitingPhase 1
Ages 18 and older · Men · Updated Jul 9, 2026 · NCT07103018Study of ORIC-944 in Patients With Metastatic Prostate Cancer
- University of Wisconsin Carbone Cancer Center, Madison
RecruitingPhase 1
Ages 18 and older · Men · Updated Jul 9, 2026 · NCT05413421Integrated Cancer Repository for Cancer Research
- Bellin Memorial Hospital, Green Bay
RecruitingObservational studyHealthy volunteers welcome
Ages 19 to 110 · All sexes · Updated Jun 29, 2026 · NCT02012699Using FAPI PET/MRI to Evaluate Prostate Cancer
- University of Wisconsin, Madison
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Jun 10, 2026 · NCT06675357International Registry for Men With Advanced Prostate Cancer (IRONMAN)
- University of Wisconsin Carbone Cancer Center, Madison
RecruitingObservational study
Ages 21 and older · Men · Updated May 22, 2026 · NCT03151629Veterans Affairs Seamless Phase II/III Randomized Trial of STAndard Systemic theRapy With or Without PET-directed Local Therapy for Oligometastatic pRosTate Cancer
- William S. Middleton Memorial Veterans Hospital, Madison, WI, Madison
- Clement J. Zablocki VA Medical Center, Milwaukee, WI, Milwaukee
RecruitingPhase 2/3
Ages 18 and older · Men · Updated Apr 8, 2026 · NCT04787744Novel ACK1 Inhibitor (R)-9b in Patients With Prostate Cancer
- University of Wisconsin Carbone Cancer Center (UWCCC) - Cancer Connect, Madison
RecruitingPhase 1
Ages 18 and older · Men · Updated Mar 20, 2026 · NCT06705686Trial of pTVG-HP+Nivo+Targeted Ablation of Resistant Lesions in Non-Castrate RecurrentOMPC
- University of Wisconsin - Madison, Madison
RecruitingPhase 1
Ages 18 and older · Men · Updated Mar 11, 2026 · NCT07090148From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.